Basal arterial pressure and responses to vasoconstrictors other than Ang II (phenylephrine, U46619, endotheline) were not modiÀ ed in SM-Arhgef1-KO mice.
Carotid intima media thickness (CIMT) is frequently increased in hypertensive patients, correlated with blood pressure levels but clinical trials have evaluated the effect of different antihypertensive drugs on CIMT with contradictory results. Because of these conÁ icting results, our work aimed to address these questions by realizing a meta-analysis on all randomized controlled trials studying the effects of different antihypertensive products on the CIMT.
Methods -We systematically reviewed all randomized controlled trials of antihypertensive treatment on CIMT. 29 trials were identiÀ ed in three databases. We conducted a combined analysis of antihypertensive effects using the overall effect.
Findings -A signiÀ cant positive overall effect size on global comparison of CIMT with antihypertensive drugs compare to placebo was found using a random effect model (-0.08 [-0.13 ; -0.03]). Overall effect sizes were signiÀ cant for ACE (-0.08 [-0.14 ; -0.02]) and beta blockers (-0.09 [-0.19 ; 0.05]) versus placebo. Data did not allow other comparison versus placebo. SigniÀ cant and beneÀ cial overall effect size was observed for Calcium antagonists compare to both ACE (0.37 [0.20 ; 0.54]) and Diuretics (-0.09 [-0.16 ; -0.02]). SigniÀ cant and beneÀ cial overall effect size was observed for AT1 compare to Beta blockers (0.61 [0.46 ; 0.77]). In subgroup analysis, signiÀ cant and beneÀ cial overall effect size was found both for low and high decrease in blood pressure, for baseline CIMT lower or equal than 0.82 in contrast with CIMT greater than 0.82 and for treatment duration less than 24 months in contrast with an increase in CIMT after 24 months.
Interpretation -anti-hypertensive treatment is associated with a signiÀ cant decrease of CIMT. Calcium channel blockers are the most effective treatment follow by ACE inhibitors. Standardization of the protocols of measurements of the CIMT is required to assess longterm effects of CIMT reduction on cardiovascular morbi-mortality.
I027

ETUDE DES MÉCANISMES DE DIFFÉRENCIATION DES CELLULES MUSCULAIRES LISSES ARTÉRIELLES EN CHONDROBLASTES ET OSTÉOBLASTES
J. SAINZ 1 , T. TROVIATI-MACIEL 1 , M. LEROUX-BERGER 1 , I. QUEGUINER 1 , H. KEMPF 1 1 Collège de France, Paris, France La calciÀ cation des vaisseaux sanguins est un problème clinique majeur puisqu'elle représente un facteur de risque de mortalité cardiovasculaire chez les patients diabétiques, en insufÀ sance rénale ou atteints d'athérosclérose. Il a récemment été suggéré que la calciÀ cation vasculaire constituerait un phénomène actif et régulé, qui implique une différenciation des cellules musculaires lisses en cellules cartilagineuses et/ou osseuses, dont la matrice extracellulaire se minéralise. Notre laboratoire s'intéresse particulièrement à cette transformation phénotypique, et vise à identiÀ er les mécanismes moléculaires sous-jacents.
AÀ n d'évaluer les capacités de différenciation des cellules musculaires lisses (CML) en chondroblastes et en ostéoblastes, nous avons isolé des CML vasculaires à partir d'aortes de souris sauvages, et les avons cultivées : 1) soit sous forme de « micropellets » en présence de cytokines (TGF-β3, Bmp2) pour favoriser une possible différenciation vers la voie chondroblastique, 2) soit en monocouche en présence de β-glycérophosphate pour inciter un engagement vers la voie ostéoblastique. Le degré de différenciation a ensuite été déterminé, à différents temps, en procédant à un certain nombre de colorations histologiques spéciÀ ques (Bleu Alcian, Bleu de Toluidine, Rouge Alizarin), ainsi qu'en analysant l'expression de gènes d'intérêt (collagènes de type 1 et 2, Sox9, Runx2, Osterix). De plus, notre groupe étudie l'impact de différents facteurs, tel le taux d'oxygénation et l'inÁ ammation, sur l'engagement des CML vers une différenciation de type chondroblastique ou ostéoblastique. Ainsi les cultures de différenciation décrites ci-dessus ont été réalisées en conditions normoxiques ou hypoxiques, et en présence ou non de cytokines inÁ ammatoires telles TNF-α.
A terme, notre objectif est d'utiliser les informations que nous avons obtenues suite à nos expériences in vitro pour mieux comprendre les processus d'initiation de la calciÀ cation in vivo, notamment dans le modèle de la souris ApoE-/-athéroscléreuse.
Methods -This study was performed in 169 French males over 60 years. Aortic stiffness was assessed by carotid/femoral pulse wave velocity (PWV). BMD and body composition were determined with a DEXA device in lumbar spine L1-L4, femoral neck and total body.
Results -Lean mass was positively correlated with the three T-scores accounting for 11.6 %, 26.6 % and 12.2 % of the variability in lumbar spine L1-L4, femoral neck and total body BMD T-scores respectively. Fat mass had no effect on BMD. However, fat mass was positively correlated with aortic PWV accounting for 9.8 % of its variability. Lean mass was not a determinant of PWV. Hypertension, diabetes and dyslipidemia were associated with higher PWV but had no effect on BMD.
Conclusions -In males from a general population over 60 years of age, bone and arterial aging are differently inÁ uenced by lean and fat mass. Our results indicate that elderly men with high lean mass and low fat mass exhibit the best arterial and bone proÀ le, with the lowest arterial stiffness and the highest BMD.
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THE REGULATION OF LARGE ARTERY STIFFNESS BY THE VASCULAR ENDOTHELIUM INCLUDES THE CONTROL OF ARTERIAL WALL VISCOSITY
J. BELLIEN 1 , M. IACOB 1 , C. THUILLEZ 1 , R. JOANNIDES 1 1 CHU de Rouen -Inserm U644, Rouen, France
Although the viscoelasticity of large arteries has been extensively investigated, few studies have focused on arterial wall viscosity (AWV) itself and its regulation by the endothelium in vivo. This is of particular importance since AWV is a major source of energy dissipation through the vascular system reducing the efÀ ciency of cardiovascular coupling.
We simultaneously measured in 8 healthy volunteers (age: 22±1 years) radial artery diameter and arterial pressure (NIUS02) before and after 8 min local infusion of L-NMMA (8 mmol/min) as NO-synthase inhibitor, tetraethylammonium (TEA: 9 mmol/ min), as blocker of calcium-activated potassium channels, the target of endothelium-derived hyperpolarizing factors (EDHF), and L-NMMA+TEA. Arterial pressure and diameter were carefully synchronized and the pressure-diameter relationship were constructed at each cardiac cycle. AWV was estimated from the ratio of the area of the hysteresis loop of the pressure-diameter relationship to the area representing the whole energy exchanged during each cardiac cycle (À gure). Radial artery stiffness was evaluated during the whole cardiac cycle by the calculation of cross-sectional distensibility and during the ventricular ejection period by the slope of the ascending loop.
L-NMMA did not modify signiÀ cantly arterial distensibility and ascending slope but, paradoxically reduced AWV (from 29.5±0.7 to 24.9±0.7 %, P=0.05). Conversely, TEA reduced arterial distensibility (from 6.50±0.19 to 5.53±0.2 10-5.kPa, P=0.002) and the ascending slope (from 1.03±0.01 to 0.86±0.03 mm.mmHg, P<0.001) and increased AWV (from 29.1±0.5 to 35.0±0.7 %, P=0.04). The combination of L-NMMA+TEA induced a more marked decrease in distensibility (from 6.86±0.24 to 4.85±0.17 10-5.kPa, P<0.001) and ascending slope (from 1.06±0.04 to 0.69±0.03 mm.mmHg, P<0.001) and increase in AWV (from 29.0±0.9 to 43.0±0.7, P=0.04) as compared with TEA alone (all P<0.05).
These results demonstrate in vivo in humans that the vascular endothelium contributes, in addition to large artery elasticity, to the regulation of AWV through the release of NO and EDHF. The old spontaneously hypertensive rat (SHR) is known to be a good experimental model that is highly analogous to essential hypertension in man but is costly and time consuming. Chronic inhibition of nitric oxide (NO) production in young adult SHR is an experimental model of malignant hypertension and chronic renal disease, very similar to old SHR¹. Considering that acute or chronic decreases in NO production in normotensive rats increase arterial stiffness, we aimed to compare the aortic stiffness between SHR/L-NAME and old SHR.
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YOUNG SPONTANEOUSLY HYPERTENSIVE RATS (SHR) WITH CHRONIC INHIBITION OF NITRIC OXIDE EXHIBIT SIMILAR AORTIC STIFFNESS TO OLD SHR
Male SHR (18 weeks old) received N-Nitro-L-Arginine Methyl Ester (L-NAME) 6 mg/kg/d in drinking water (SHR/L-NAME) for 2 weeks and were compared to SHR and Wistar Kyoto rats (WKY). Moreover, two groups are composed of 55 weeks aged SHR (Old SHR) and WKY (Old WKY). Under anesthesia, two catheters were introduced in the left common carotid artery and the left femoral artery to measure central and peripheral blood pressure and assess aortic stiffness with pulse wave velocity (PWV= distance between the tips of the two catheters / transit time), β-index (2.11x(PWV²/Diastolic blood pressure)), ampliÀ cation and pulse pressure (PP).
At 20 weeks, although SHR have higher central systolic blood pressure (SBP) than WKY (201±7 mmHg vs. 154±4 mmHg), no signiÀ cant difference in PWV, PP, ampliÀ cation and β-index was observed between these two groups. With age, old WKY have higher SBP (181±8 mmHg) and higher PWV (6.7±0.5 m/s) and β-index (0.70±0.08) than young WKY. Old SHR exhibit higher SBP (252±13 mmHg), PWV (9.3±0.7 m/s), PP (71±7 mmHg), β-index (1.08±0.16) than old WKY and young SHR (PWV=6.3±0.2 m/s, PP=39±3 mmHg and β-index=0.50±0.03). Young SHR, after 2 weeks of L-NAME administration, have higher SBP (238±10 mmHg) and aortic stiffness (PWV=8.6±0.6 m/s, PP=54±6 mmHg and β-index=0.89±0.14) than young SHR and possess the aortic stiffness observed in old SHR.
